The Flagship Study: A 12-Week Phase Ii Study To Evaluate The Efficacy And Safety Of Aqx-1125 Following Exacerbations In Patients With Chronic Obstructive Pulmonary Disease (COPD) By Targeting The Ship1 Pathway

被引：0
|
作者：
Shrewsbury, S. B. [1 ,2 ]
Bjermer, L. [2 ]
Vestbo, J. [3 ]
Kuna, P. [4 ]
Saarelainen, P. [5 ]
Balint, B. [6 ]
Kalia, V. [1 ]
Tam, P. [1 ]
MacKenzie, L. [1 ]
机构：
[1] Aquinox Pharmaceut Inc, Richmond, BC, Canada
[2] Lund Univ, Lund, Sweden
[3] Univ Southern Denmark, Odense, Denmark
[4] Med Univ Lodz, Barlicki Univ Hosp, Lodz, Poland
[5] Univ Helsinki, Cent Hosp, Helsinki, Finland
[6] Csongrad Megyei Mellkasi Betegsegek Szakkorhaza, Deszk, Hungary
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2889
引用
收藏
页数：1
相关论文
共 38 条
  • [21] Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase IIIb Study
    Beier, Jutta
    Kirsten, Anne-Marie
    Mroz, Robert
    Segarra, Rosa
    Chuecos, Ferran
    Caracta, Cynthia
    Garcia Gil, Esther
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 511 - 522
  • [22] A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, 12-WEEK, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
    Schweitzer, P. K.
    Rosenberg, R.
    Zammit, G. K.
    Gotfried, M.
    Chen, D.
    Li, J.
    Carter, L. P.
    Wang, H.
    Lu, Y.
    Black, J.
    Strohl, K. P.
    SLEEP, 2017, 40 : A237 - A237
  • [23] EFFICACY OF ACLIDINIUM BROMIDE COMPARED WITH TIOTROPIUM AND PLACEBO IN SYMPTOMATIC PATIENTS WITH MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): POST-HOC ANALYSIS OF A PHASE IIIB STUDY
    Beier, J.
    Mroz, R.
    Chuecos, F.
    Garcia Gil, E.
    THORAX, 2015, 70 : A139 - A139
  • [24] CONNECT1-EDO51: a 12-week open-label Phase 2 study to evaluate PGN-EDO51 safety and efficacy in people with Duchenne amenable to exon 51 skipping
    Mellion, M.
    McMillan, H.
    Chrestian, N.
    Gonorazky, H.
    O'Connell, C.
    Vacca, S.
    Peterson, M.
    Marcos, B.
    Batra, S.
    Lonkar, P.
    Holland, A.
    Foy, J.
    Lamore, S.
    Garg, B.
    Yu, S.
    Larkindale, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [25] Safety, Pharmacokinetics and Immunogenicity of the Anti-Interleukin-33 Antibody, Tozorakimab: Results of a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease
    Reid, F.
    Singh, D.
    Albayaty, M.
    Moate, R.
    Jimenez, E.
    Sadiq, M. W.
    Howe, D.
    Scott, I. C.
    Killick, H.
    Krishnan, S.
    Godwood, A.
    Shukla, A.
    Hewitt, L.
    Lei, A.
    Kell, C.
    Pandya, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] FUNCTION AND WORK PRODUCTIVITY MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
    Bogan, R.
    Feldman, N. T.
    Stern, T.
    Villa, K. F.
    Chen, D.
    Carter, L. P.
    Wang, H.
    Lu, Y.
    Black, J.
    Drake, C.
    SLEEP, 2017, 40 : A236 - A236
  • [27] Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Randomized, 42-Day Study
    Siler, Thomas M.
    Moran, Edmund J.
    Barnes, Chris N.
    Crater, Glenn D.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2020, 7 (02): : 99 - 106
  • [28] Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study
    Chen, Di
    Zhang, Shunhua
    Bian, Ailing
    Hong, Jing
    Deng, Yingping
    Zhang, Mingchang
    Chen, Wei
    Shao, Yan
    Zhao, Jialiang
    MEDICINE, 2019, 98 (31)
  • [29] FUNCTION, WORK PRODUCTIVITY, AND QUALITY OF LIFE MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF SOLRIAMFETOL (JZP-110) FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
    Drake, C.
    Bogan, R.
    Benes, H.
    Stern, T.
    Villa, K. F.
    Chen, D.
    Carter, L.
    Wang, H.
    Black, J.
    Weaver, T.
    SLEEP MEDICINE, 2017, 40 : E81 - E82
  • [30] Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease
    Besarab, Anatole
    Salifu, Moro O.
    Lunde, N. Martin
    Bansal, Vinod
    Fishbane, Steven
    Dougherty, Frank C.
    Beyer, Ulrich
    CLINICAL THERAPEUTICS, 2007, 29 (04) : 626 - 639
1234